Quality by Design– tag –
-
Pharma 4.0 Drives Digital Integration: LIMS, AI, and Digital Twins Revolutionize Pharmaceutical Manufacturing
Technology Networks UK Overview Pharma 4.0 is advancing digital integration, leveraging LIMS, AI algorithms, and digital twin technology to eliminate data silos and foster connected pharmaceutical manufacturing. Digital twins extend the ... -
FDA-Endorsed Process Analytical Technology (PAT) Revolutionizes Pharmaceutical Manufacturing Quality with Real-time Measurement
Technology Networks UK Overview This article elucidates Process Analytical Technology (PAT) as an FDA-endorsed framework for real-time measurement and control in pharmaceutical manufacturing. PAT fundamentally shifts quality assurance fr... -
Bioprocess Analytics Optimizes Biologics Manufacturing with Digital Twins and AI for Predictive Quality Control
World Pharma Today USA Overview This article highlights the strategic application of bioprocess analytics and advanced algorithms to optimize biologics manufacturing. By leveraging real-time data and sophisticated machine learning models... -
Industrializing Cell & Gene Therapy Manufacturing: Key Takeaways from Advanced Therapies USA Conference
BioProcess International USA Overview The Advanced Therapies USA conference highlighted the critical shift in cell and gene therapy (CGT) manufacturing towards large-scale industrialization through process consolidation, closed automatio... -
FDA Finalizes Guidance on CMC Flexibility for Cell and Gene Therapies, Expediting Access to Advanced Treatments
Regulatory Focus USA Overview The U.S. FDA has issued final guidance outlining flexible Chemistry, Manufacturing, and Controls (CMC) requirements for cell and gene therapy (CGT) products, recognizing their inherent complexities compared ...
12